Citation: | HUANG Xian-da, SHI Wei, GONG Quan, LI Shi-juan, ZHANG Li-juan, ZHOU Chun-yan, CHEN Xi, ZHUANG Li, WANG Cun-de. Clinical significance of the expression of algogenic substances and the change in immune function before and after control of cancer pain[J]. Chinese Journal of General Practice, 2022, 20(2): 212-215. doi: 10.16766/j.cnki.issn.1674-4152.002315 |
[1] |
吴艺舟, 林子晨, 孙杰. 基于肿瘤坏死因子TNF-α的癌症疼痛机制及临床治疗策略[J]. 医学理论与实践, 2018, 31(18): 2716-2719. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLL201818012.htm
|
[2] |
AL M S, FARHAT K, NEDJADI T, et al. Association of interleukin-6 and other cytokines with self-reported pain in prostate cancer patients receiving chemotherapy[J]. Pain Med, 2018, 19(5): 1058-1066. doi: 10.1093/pm/pnx145
|
[3] |
CHONG D, SHAO L, YANG Y, et al. Correlations of cancer pain degree with levels of β-EP, CGRP and PGE2 and the effects of oxycontin on them[J]. J BUON, 2018, 23(5): 1552-1557. http://www.ncbi.nlm.nih.gov/pubmed/30570885
|
[4] |
CHOI H Y, LEE C H. Can beta-endorphin be used as a biomarker for chronic low back pain? A meta-analysis of randomized controlled trials[J]. Pain Med, 2019, 20(1): 28-36. doi: 10.1093/pm/pny186
|
[5] |
VELASCO M, O'SULLIVAN C, SHERIDAN G K. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain[J]. Neuropharmacology, 2017, 113(Pt B): 608-617. http://core.ac.uk/download/pdf/42557259.pdf
|
[6] |
TREEDE R D, RIEF W, BARKE A, et al. Chronic pain as a symptom or a disease: The IASP classification of chronic pain for the international classification of diseases (ICD-11)[J]. Pain, 2019, 160(1): 19-27. doi: 10.1097/j.pain.0000000000001384
|
[7] |
HAN L, JIANG J, XUE M, et al. Sonic hedgehog signaling pathway promotes pancreatic cancer pain via nerve growth factor[J]. Reg Anesth Pain Med, 2020, 45(2): 137-144. doi: 10.1136/rapm-2019-100991
|
[8] |
李琪琪, 林健清. 小胶质细胞活化参与骨癌痛机制的研究进展[J]. 中国疼痛医学杂志, 2020, 26(9): 685-688. doi: 10.3969/j.issn.1006-9852.2020.09.009
|
[9] |
ZHAO D, HAN D F, WANG S S, et al. Roles of tumor necrosis factor-α and interleukin-6 in regulating bone cancer pain via TRPA1 signal pathway and beneficial effects of inhibition of neuro-inflammation and TRPA1[J]. Mol Pain, 2019, 15: 1744806919857981. DOI: 10.1177/1744806919857981.
|
[10] |
SCHEFF N N, YE Y, BHATTACHARYA A, et al. Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation[J]. Pain, 2017, 158(12): 2396-2409. doi: 10.1097/j.pain.0000000000001044
|
[11] |
冯馨锐, 崔雨舒, 何志涛, 等. 肿瘤坏死因子-α的生物学功能研究进展[J]. 吉林医药学院学报, 2019, 40(1): 66-68. https://www.cnki.com.cn/Article/CJFDTOTAL-JLDS201901030.htm
|
[12] |
BARKER P A, MANTYH P, ARENDT N L, et al. Nerve growth factor signaling and its contribution to pain[J]. J Pain Res, 2020, 13: 1223-1241. doi: 10.2147/JPR.S247472
|
[13] |
OBREJA O, RUKWIED R, NAGLER L, et al. Nerve growth factor locally sensitizes nociceptors in human skin[J]. Pain, 2018, 159(3): 416-426. doi: 10.1097/j.pain.0000000000001108
|
[14] |
DENK F, BENNETT D L, MCMAHON S B. Nerve growth factor and pain mechanisms[J]. Annu Rev Neurosci, 2017, 40: 307-325. doi: 10.1146/annurev-neuro-072116-031121
|
[15] |
GUI Q, XU C, ZHANG L, et al. A new rat model of bone cancer pain produced by rat breast cancer cells implantation of the shaft of femur at the third trochanter level[J]. Cancer Biol Ther, 2013, 14(2): 193-199. doi: 10.4161/cbt.23291
|
[16] |
SCARBOROUGH B M, SMITH C B. Optimal pain management for patients with cancer in the modern era[J]. CA Cancer J Clin, 2018, 68(3): 182-196. doi: 10.3322/caac.21453
|
[17] |
崔爽, 国仁秀, 郑莹. 老年癌症患者疼痛评估工具的研究进展[J]. 中国医药导报, 2018, 15(32): 42-45. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201832010.htm
|
[18] |
卢正义, 胡壮文. 鞘内吗啡泵联合无线自控镇痛泵对于晚期癌痛患者细胞免疫功能和生存期的影响[J]. 中国药物与临床, 2019, 19(5): 750-752. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201905029.htm
|
[19] |
彭仁, 王永业. 镇痛疗法对肿瘤患者血T淋巴细胞亚群的影响[J]. 中国社区医师, 2018, 34(8): 93, 95. https://www.cnki.com.cn/Article/CJFDTOTAL-XCYS201808057.htm
|
[20] |
孙峰, 鲍扬漪, 葛磊, 等. 癌痛对抑郁及免疫功能的影响[J]. 现代肿瘤医学, 2018, 26(8): 1263-1265. doi: 10.3969/j.issn.1672-4992.2018.08.029
|